In middle-income countries such as those in Latin America it has not yet arrived, despite the fact that their residents took part in the clinical trials. “How can Latin America continue to be excluded from licenses for life-saving medicines?” How can Latin America continue to be excluded from licenses for life-saving medicines? In Latin America, 2.6 million people live with HIV and, in 2025, there were 28,000 deaths related to the disease. While the global trend has been a decline in cases, the opposite has happened in Latin America: between 2010 and 2024 cases increased by 13%.